This study examined preliminary outcomes of an innovative model where overdose survivors receive ambulance-based buprenorphine and addiction treatment linkage (Recovery Research Institute)
Bibliography: Interventions – Treatment
Searching the grey literature to access research on illicit drug use, blood borne virus, and coverage of interventions among people who are incarcerated
This technical report outlines websites associated with various databases and organisations that could provide grey literature resources related to illicit drug use, blood borne virus, and coverage of interventions amongst people who are incarcerated (NDARC)
Shooting Up: infections among people who inject drugs in the UK
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom (UK Health Security Agency)
Interim monitoring report on statutory funded residential rehabilitation placements
Placements approved by Alcohol and Drug Partnerships between 1 April 2021 and 31 December 2022 (Public Health Scotland)
Substance misuse treatment in secure settings: 2021 to 2022
Statistics for alcohol and drug misuse treatment in prisons and other secure settings from the National Drug Treatment Monitoring System (NDTMS)
Women and drugs: health and social responses
This miniguide is one of a larger set, which together comprise Health and social responses to drug problems: a European guide. It provides an overview of the most important aspects to consider when planning or delivering health and social responses for women who use drugs, and reviews the availability and effectiveness of the responses (EMCDDA)
Drug and Alcohol Treatment and Recovery Workforce Programme
This programme aims to transform the lives of those affected by drug and alcohol misuse by improving the quality and capacity of the drug and alcohol treatment and recovery workforce (NHS Health Education England)
Taking the initiative: how England is eliminating hepatitis C
This report explores the development of the programme, how several of the key initiatives have worked and developed over time, and next steps in the programme (HCV Action)
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA (3,4-methylenedioxy-methamphetamine) can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions (Australian Government)
Hepatitis C in the UK 2023
Working to eliminate hepatitis C as a public health threat (Health Security Agency)
Substance misuse treatment for young people: statistics 2021 to 2022
Alcohol and drug treatment data for young people under 18, from the National Drug Treatment Monitoring System (Office for Health Improvement and Disparities)
Substance misuse treatment for adults: statistics 2021 to 2022
Statistics on alcohol and drug misuse treatment for adults from the National Drug Treatment Monitoring System (NDTMS)
Party Panel: developing theory- and evidence-based health promotion in nightlife settings
This paper describes the development and results of a web survey, named the Party Panel, that addresses emerging risks in nightlife settings (EMCDDA)
Drug Abuse Warning Network: Findings from Drug-Related Emergency Department Visits, 2021
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (4) the identification of drugs new to DAWN’s Drug Reference Vocabulary (SAMHSA)
Cannabis in Australia
More than a third of Australians aged over 14 have used cannabis at least once – 37%, or 7.6 million people. Around 2.4 million Australians used cannabis in 2019, as did 200 million people worldwide (Penington Institute)
Drug and alcohol services – co-occurring substance use and mental health concerns: literature and evidence review
This report provides a rapid review of the literature on co-occurring substance use and mental health concerns and the integration of mental health and substance use services in Scotland (Scottish Government)
HIV Action Plan monitoring and evaluation framework
The 2021 data has shown positive signs of recovery, but that recovery is uneven. The number of all people with diagnosed HIV infection and in care who were treated and virally suppressed remained extremely high between 2019 and 2021 (UK Government)
Drug-related hospital statistics – Scotland 2021 to 2022
This release by Public Health Scotland (PHS) presents information on hospital activity relating to illicit drug use in Scotland during the period 1996/97 to 2021/22. The topics covered include: the number of hospital stays, the number and characteristics of patients, substances used and geographical variations. These data are published in a dashboard and full report
National Mission on Drugs: annual report 2021 to 2022
Sets out the progress made between January 2021 and 31 March 2022 by national government, local government and third sector partners towards reducing drug deaths and improving the lives of those impacted by drugs in Scotland Download (Scottish Government)
Ending the exclusion
Care, treatment and support for people with mental ill health and problem substance use in Scotland
- 1
- 2
- 3
- …
- 17
- Next Page »
